Skip to content

Comparison of the Anesthetic Effects and Recovery Quality between Hydromorphone and Sufentanil for Bronchoalveolar Lavage in Pediatric Patients

Comparison of the Anesthetic Effects and Recovery Quality between Hydromorphone and Sufentanil for Bronchoalveolar Lavage in Pediatric Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096808
Enrollment
Unknown
Registered
2025-02-07
Start date
2025-02-20
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia eligible for bronchoalveolar lavage

Interventions

Control group:Induced anesthesia with remifentanil 1.0 µg/kg, propofol 3 mg/kg, and rocuronium 0.3 mg/kg
Sufentanil group:Induced anesthesia with sufentanil 1.0 µg/kg, propofol 3 mg/kg, and rocuronium 0.3 mg/kg
Hydromorphone group:Induced anesthesia with hydromorphone 0.1mg/kg, propofol 3 mg/kg, and rocuronium 0.3 mg/kg

Sponsors

Foshan Maternity & Child Healthcare Hospital,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1.Select children who are planned to undergo bronchoalveolar lavage under fiberoptic bronchoscopy at Foshan Maternal and Child Health Hospital; 2.Age 3 to 6 years old, gender not limited; 3.American Society of Anesthesiologists (ASA) classification grades ? to ?; 4.The family members sign the informed consent form for the clinical trial.

Exclusion criteria

Exclusion criteria: 1.Acute exacerbation of cough, hemoptysis, or SpO2 < 95% before surgery; 2.Children with asthma or difficult airway; 3.Children with severe cardiovascular, hematological, renal, or liver diseases; 4.Those with mental illness who cannot cooperate; 5.History of allergy to anesthetic drugs; 6.Contraindications for laryngeal mask airway; 7.Those whom the investigator deems unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Anesthetic Quality;Cough Score;

Secondary

MeasureTime frame
At least one adverse respiratory event occurred;Emergence agitation and sedation score;Extubation time;

Countries

China

Contacts

Public ContactHua Liang

Foshan Maternal and Child Health Hospital.

lhlh2003@126.com+86 18038862236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026